A randomised phase 2 trial investigating the additional benefit of hydroxychloroquine (HCQ) to short course radiotherapy (SCRT) in patients aged 70 years and older with high grade gliomas (HGG)

Registry ID

EUCTR2012-000091-41

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

University College London

Start date

2012-08-20

Completion date

2019-07-25

Last update

2026-08-16

Conditions

• High Grade glioma

Summary

To examine the effect on one year survival of giving hydroxychloroquine (HCQ) with short course radiotherapy (SCRT) to high grade gliomas (HGG) patients aged ≥ 70 years Primary endpoint •One-year survival will be calculated from the proportion of patients surviving the first year

Locations

• , , UK

View on source registry